Fermentalg SA (EPA:ALGAE)

Market Cap	37.22M -15.0%
Revenue (ttm)	13.20M +3.2%
Net Income	-9.31M
EPS	-0.09
Shares Out	96.06M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	145,671
Open	0.3840
Previous Close	0.3800
Day's Range	0.3810 - 0.4140
52-Week Range	0.3505 - 0.6400
Beta	1.06
Analysts	Strong Buy
Price Target	0.50 (+27.74%)
Est. Earnings	Apr 2, 2027

About Fermentalg

Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw materials for industry from their CO2 emissions. The company was incorporated in 2009 and is headquartered in Libourne, France.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Employees: 62
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALGAE

Financial Performance

In 2025, Fermentalg's revenue was 13.38 million, an increase of 16.41% compared to the previous year's 11.50 million. Losses were -9.44 million, -26.71% less than in 2024.

Analyst Summary

According to 2 analysts, the average rating for ALGAE stock is "Strong Buy." The 12-month stock price target is €0.50, which is an increase of 27.74% from the latest price.

Price Target

€0.50

(27.74% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 9, 2026

Data Sources Report a data error